Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
What can we learn about schizophrenia from studying the human model, drug-induced psychosis?
Murray RM, Paparelli A, Morrison PD, Marconi A, Di Forti M. Murray RM, et al. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):661-70. doi: 10.1002/ajmg.b.32177. Am J Med Genet B Neuropsychiatr Genet. 2013. PMID: 24132898 Review.
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.
Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM. Morrison PD, et al. Psychol Med. 2009 Oct;39(10):1607-16. doi: 10.1017/S0033291709005522. Epub 2009 Apr 1. Psychol Med. 2009. PMID: 19335936 Clinical Trial.
Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review.
Hobbs M, Kalk NJ, Morrison PD, Stone JM. Hobbs M, et al. Among authors: morrison pd. Eur Neuropsychopharmacol. 2018 Dec;28(12):1289-1304. doi: 10.1016/j.euroneuro.2018.10.004. Epub 2018 Nov 16. Eur Neuropsychopharmacol. 2018. PMID: 30454908
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
Tunbridge EM, Dunn G, Murray RM, Evans N, Lister R, Stumpenhorst K, Harrison PJ, Morrison PD, Freeman D. Tunbridge EM, et al. J Psychopharmacol. 2015 Nov;29(11):1146-51. doi: 10.1177/0269881115609073. Epub 2015 Oct 13. J Psychopharmacol. 2015. PMID: 26464454 Clinical Trial.
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms.
Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen R, Holt D, Wilson D, Sumich A, McGuire P, Murray RM, Kapur S, Ffytche DH. Morrison PD, et al. Neuropsychopharmacology. 2011 Mar;36(4):827-36. doi: 10.1038/npp.2010.222. Epub 2010 Dec 8. Neuropsychopharmacology. 2011. PMID: 21150914 Free PMC article. Clinical Trial.
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.
Paparelli A, Di Forti M, Morrison PD, Murray RM. Paparelli A, et al. Front Behav Neurosci. 2011 Jan 17;5:1. doi: 10.3389/fnbeh.2011.00001. eCollection 2011. Front Behav Neurosci. 2011. PMID: 21267359 Free PMC article.
From real-world events to psychosis: the emerging neuropharmacology of delusions.
Morrison PD, Murray RM. Morrison PD, et al. Schizophr Bull. 2009 Jul;35(4):668-74. doi: 10.1093/schbul/sbp049. Epub 2009 Jun 1. Schizophr Bull. 2009. PMID: 19487337 Free PMC article.
What is the mechanism whereby cannabis use increases risk of psychosis?
Luzi S, Morrison PD, Powell J, di Forti M, Murray RM. Luzi S, et al. Neurotox Res. 2008 Oct;14(2-3):105-12. doi: 10.1007/BF03033802. Neurotox Res. 2008. PMID: 19073418 Review.
Cannabis, the mind and society: the hash realities.
Murray RM, Morrison PD, Henquet C, Di Forti M. Murray RM, et al. Nat Rev Neurosci. 2007 Nov;8(11):885-95. doi: 10.1038/nrn2253. Nat Rev Neurosci. 2007. PMID: 17925811 Review.
92 results
Jump to page